Shaojing He

No ORCID on file · 1 paper in corpus

observational 2024

Effect of medroxyprogesterone acetate dose in progestin-primed ovarian stimulation on pregnancy outcomes in poor ovarian response patients with different body mass index levels

Frontiers in endocrinology ·doi:10.3389/fendo.2024.1352522

BACKGROUND: For the poor ovarian response (POR) population, the relationship between medroxyprogesterone acetate (MPA) dose in progestin-primed ovarian stimulation (PPOS) and clinical outcome is still unclear. This study aims to explore the…